ARTICLE | Company News
Flag Therapeutics, Duquesne University deal
December 16, 2013 8:00 AM UTC
Flag acquired exclusive, worldwide rights to anti-antiogenic/anti- tubulin compounds and folate-targeted anti-cancer compounds developed at the university. The agreement includes IP and a compound lib...